Celcuity Inc (CELC.OQ)
CELC.OQ on NASDAQ Stock Exchange Capital Market
26.18USD
17 Aug 2018
26.18USD
17 Aug 2018
Change (% chg)
$0.04 (+0.15%)
$0.04 (+0.15%)
Prev Close
$26.14
$26.14
Open
$26.02
$26.02
Day's High
$26.42
$26.42
Day's Low
$26.02
$26.02
Volume
2,888
2,888
Avg. Vol
9,213
9,213
52-wk High
$29.19
$29.19
52-wk Low
$11.10
$11.10
About
Celcuity, Inc. is a cellular analysis company. The Company is focused on discovering new cancer sub-types and commercializing diagnostic tests designed to significantly improve the clinical outcomes of cancer patients treated with targeted therapies. The Company’s proprietary CELx diagnostic platform uses a patient’s living... (more)
Overall
| Beta: | -- |
| Market Cap(Mil.): | $126.97 |
| Shares Outstanding(Mil.): | 9.72 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| CELC.OQ | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 85.68 | 32.76 |
| EPS (TTM): | -0.48 | -- | -- |
| ROI: | -- | 1.78 | 14.61 |
| ROE: | -- | 3.28 | 16.33 |
BRIEF-Celcuity Reports Q4 Adjusted Non-Gaap Loss Per Share $0.14
* CELCUITY REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS
Estimates